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Abstract 
Background 
A growing body of scientific research is suggesting that end-of-life care and decision making 
may differ between age groups and that elderly patients may be the most vulnerable to 
exclusion of due care at the end of life. This study investigates age-related disparities in the 
rate of end-of-life decisions with a possible or certain life shortening effect (ELDs) and in the 
preceding decision making process in Flanders, Belgium in 2007, where euthanasia was 
legalised in 2002. Comparing with data from an identical survey in 1998 we also study the 
plausibility of the ‘slippery slope’ hypothesis which predicts a rise in the rate of 
administration of life ending drugs without patient request, especially among elderly patients, 
in countries where euthanasia is legal. 
Method 
We performed a post-mortem survey among physicians certifying a large representative 
sample (n = 6927) of death certificates in 2007, identical to a 1998 survey. Response rate was 
58.4%. 
Results 
While the rates of non-treatment decisions (NTD) and administration of life ending drugs 
without explicit request (LAWER) did not differ between age groups, the use of intensified 
alleviation of pain and symptoms (APS) and euthanasia/assisted suicide (EAS), as well as the 
proportion of euthanasia requests granted, was bivariately and negatively associated with 
patient age. Multivariate analysis showed no significant effects of age on ELD rates. Older 
patients were less often included in decision making for APS and more often deemed lacking 
in capacity than were younger patients. Comparison with 1998 showed a decrease in the rate 
of LAWER in all age groups except in the 80+ age group where the rate was stagnant. 
Conclusion 
Age is not a determining factor in the rate of end-of-life decisions, but is in decision making 
as patient inclusion rates decrease with old age. Our results suggest there is a need to focus 
advance care planning initiatives on elderly patients. The slippery slope hypothesis cannot be 
confirmed either in general or among older people, as since the euthanasia law fewer 
LAWER cases were found. 
Keywords 
Ageism, Age inequalities, End of life, End-of-life decisions, Slippery slope, Euthanasia, 
Palliative care, Belgium 
Background 
Life expectancy in developed countries has risen considerably during the last century [1,2]. 
This has had a profound impact on the age distribution of populations: the number and 
proportion of elderly people is steadily rising and is projected to increase further. The ‘baby 
boom generation’ born after WWII is reaching old age. The proportion of elderly people 
among decedents is also rising; in Belgium (Flanders) the proportion of those dying aged 80 
or over has recently reached 50% [3]. 
As death nowadays mostly follows from chronic and degenerative disease with a prolonged 
dying process rather than from acute infectious disease, care provision in the end stages of 
life has become of great interest to patients, health care workers and national health care 
systems. A growing body of scientific literature shows that provision of end-of-life care can 
vary between patients of different ages [4-11]. Older patients have been reported to have less 
access to specialist or palliative care and to receive adequate pain and symptom treatment less 
often [4,11], to have life-prolonging treatment forgone more often [8,11-14], to have do not 
resuscitate and do not hospitalise orders more often [8,15-17], and to be excluded from 
decision making more often [11,18,19]. Also, research has found that physicians and patients’ 
family are less inclined to continue or intensify end-of-life treatment in older than in younger 
patients [4,20,21]. Patients themselves may also base decisions concerning their treatment 
partly on whether they have lived a long and fulfilling life [11,14,20,22]. These findings thus 
indicate significant differences or inequalities between different ages when it comes to end-
of-life care and decision making. This is of great importance to health care policy makers as 
it may imply inequitable distribution of scarce medical resources [15,23]. 
So, elderly patients are generally viewed as being more vulnerable to exclusion of due care. 
Many opponents of legalised euthanasia warn of a ‘slippery slope’ towards more unethical 
practice among vulnerable patient groups such as older patients. These critics predict a rise in 
life ending without explicit request from the patient in general, and especially in elderly 
patient groups, in countries where euthanasia is legally regulated [24,25]. 
In this report we investigate age-related disparities in end-of-life decisions (ELDs) with a 
possible or certain life shortening effect in Flanders, Belgium in 2007. The studied decisions 
are intensified drug administration for pain and other symptoms in doses with life shortening 
as possible effect, decisions to withdraw or withhold potentially life-prolonging treatment and 
physician-assisted dying ie the prescribing, supplying or administering of lethal drugs (ie 
euthanasia, physician-assisted suicide and life ending acts without explicit patient request). 
Belgium is one of only three countries in the world where euthanasia is legal (since 2002) 
under strict conditions [26]. In order to establish whether the ‘slippery slope’ argument holds 
true, particularly for the supposedly vulnerable old, data presented from the 2007 survey will 
be supplemented where necessary with data from an identical survey conducted in 1998, 
before the euthanasia law was passed. We pose the following research questions: 1) are there 
differences in 2007 in the incidence of the various end-of-life decisions across age groups 2) 
what are the incidence shifts between 1998 and 2007 in the different age groups 3) what is 
the preceding decision making process and 4) does the formulation and granting of 
euthanasia requests differ in incidence across age groups. 
Method 
Study design 
We performed a death certificate survey in Flanders, the Flemish-speaking half of Belgium 
which has about six million inhabitants and approximately 55,000 deaths per year. This study 
was identical to a study performed in 1998 [27]. A stratified random sample of deaths was 
drawn by the central administration authority for death certificates, the Flemish Agency for 
Care and Health. All deaths between June 1
st
 2007 and November 30
th
 2007 of Belgian 
residents aged one year or older were first assigned to one of four strata based on the 
underlying cause of death, as indicated on the death certificate, and the estimated 
corresponding likelihood of an end-of-life decision. Sampling fractions for each stratum 
increased with this likelihood. Such disproportionate sampling was not done in 1998. This 
resulted in a sample of 6,927 deaths, about 25% of all deaths in the studied months and about 
12% of all deaths in 2007. 
Every certifying physician was sent a five-page questionnaire for a maximum of five cases, 
with at most three reminders in cases of non-response. A lawyer was involved in the mailing 
procedure as intermediary between responding physicians, researchers and the Flemish 
Agency for Care and Health to guarantee that completed questionnaires could never be linked 
to a particular patient or physician. Only coded patient information from the death certificates 
was linked to the corresponding completed questionnaires. By guaranteeing anonymity for 
physicians the potential risk of social desirability bias was decreased. After data collection a 
one-page questionnaire was mailed to all non-responding physicians asking for the reasons 
for not participating. The study design, sampling and mailing procedure are described in 
detail elsewhere [28]. 
Of the 6,927 questionnaires mailed to physicians in 2007, 3,623 were returned. From the non-
response analyses we found that response was not possible for 725 deaths (because the 
physician had changed workplace and did not have access to the patient’s medical file, 
because the patient could not be identified, because the physician was not the treating 
physician and did not know who this was or because the questionnaire had never reached the 
physician). The response rate was 58.4% (3,623/6,202 eligible cases). The response rate in 
1998 was 48.1% (1925/3999). 
Questionnaire 
The 2007 questionnaire was identical to the one used in 1998 [27] and was validated through 
testing by a panel of physicians. It first asked whether death had been sudden and 
unexpected. If this question was answered negatively (and hence an end-of-life decision prior 
to death would not be precluded) the physician was asked whether he/she had: 1) withheld or 
withdrawn medical treatment taking into account (NTD) or explicitly intending (NTD+) the 
hastening of the patient’s death 2) intensified the alleviation of pain and/or other symptoms 
with drugs taking into account (APS) or co-intending (APS+) the possible hastening of death 
and 3) administered, supplied, or prescribed drugs with the explicit intention of hastening 
death. If in the latter case the drugs had been administered by someone other than the patient 
at the patient’s explicit request or prescribed/supplied and self-administered, it was classified 
as euthanasia or physician-assisted suicide (EAS). If there had been no explicit request from 
the patient, the act was classified as a life ending act – by administration of drugs – without 
explicit patient request (LAWER). An end-of-life decision is thus defined as a medical 
decision at the end of a patient’s life that has a potential or certain life shortening effect. 
In many cases more than one end-of-life decision can be made in relation to the same patient. 
Because asking the same questions about the decision making process preceding every ELD 
made would overburden the respondent, we asked only about decision making exclusively for 
the most important decision. We defined this as the decision with the most explicit life 
shortening intention and in case of two decisions with similar life shortening intention, 
administering drugs prevailed over withholding or withdrawing treatment. Questions about 
the preceding decision making process were: whether the decision had been discussed with 
the patient, family and other professional caregivers and whether there had been a request by 
the patient. If no discussion had taken place with the patient, physicians were asked whether 
the patient was deemed lacking in capacity and whether the patient had ever, implicitly or 
explicitly, expressed a wish for life ending. The questionnaire also asked about the reasons 
for coming to the most important decision. Independently of whether an end-of-life decision 
had been made, an additional question was posed whether the patient had made a request for 
euthanasia that had not been granted and if so, for what reasons. Demographic and clinical 
patient data were obtained from the death certificates, and linked anonymously after data 
collection. 
Analysis 
The response samples were corrected for disproportionate stratification (2007) and adjusted 
to be representative of all deaths for each year (1998 and 2007) for age, sex, place and cause 
of death. We selected the non-sudden deaths as denominator in all analyses. Euthanasia and 
assisted suicide were grouped together given that there were only five assisted suicide cases. 
For incidence estimates and comparison of estimates between 1998 and 2007, all ELDs made 
in each patient were included in the analysis. The most important ELD was taken into 
account in the analysis of the decision making process because questions about decision 
making were only posed for the most important ELD. Bivariate percentages were calculated 
and logistic regressions were performed to determine bivariate and multivariate p-values (age 
entered as categorical variable). A p-value of <0.05 is considered to indicate statistical 
significance. All statistical analyses were done using SPSS 17.0. 
Results 
Socio-demographic and clinical characteristics 
In Flanders, Belgium in 2007 68.1% of deaths were deemed non-sudden and expected (data 
not shown). Decedents older than 80 years are more often female, widowed and with lower 
levels of education than are younger decedents (Table 1). They are also more likely to die in a 
care home as opposed to in hospital and less often from cancer than their younger 
counterparts. Instead, death at old age is associated with more cardiovascular and respiratory 
disease. 
Table 1 Socio-demographic and clinical characteristics of non-sudden deaths 2007 
(weighted %) 
  Age (yrs)  
Total −65 65-79 80+ p-value (Chi²) 
N (unweighted) 2729 550 972 1207  
% In sample (weighted) 100 15,8 32,5 51,7  
Sex     <0,001 
male 47,3 54,5 59,4 37,6  
female 52,7 45,5 40,6 62,4  
Marital status     <0,001 
married 46,3 67,0 62,1 30,0  
unmarried/divorced 14,3 28,1 14,4 10,0  
widowed 39,4 4,9 23,4 60,0  
Education     <0,001 
none or primary 36,0 15,2 31,6 45,1  
lower secondary 18,5 20,6 23,7 14,6  
higher secondary/higher 17,8 38,3 19,6 10,5  
unknown 27,6 26,0 25,1 29,8  
Cause of death     <0,001 
cancer 35,4 63,2 46,4 20,1  
cardiovascular 29,2 15,2 20,7 38,7  
respiratory 12,0 4,6 11,6 14,5  
neurological 4,1 3,6 4,7 3,9  
other 19,3 13,4 16,5 22,8  
Place of death     <0,001 
hospital 51,2 62,6 60,3 41,9  
at home 20,9 30,7 24,7 15,5  
care home 25,2 1,5 12,1 40,6  
other 2,8 5,2 2,9 2,0  
Incidence of ELDs in 2007 and comparison with 1998 
In Table 2 the incidence of the various ELDs across age groups is given. For intensified 
alleviation of pain and symptoms (APS) a decrease in incidence with age is noticeable in 
bivariate analysis (p > .001). There is also a negative association with age (p = .017) in 
relation to pain and symptom alleviation with life shortening co-intention (APS+). The 
associations disappear however in multivariate analysis under the influence of cause of death 
(not in table). Non-treatment decision (NTD) incidence in 2007 remains relatively stable 
across age groups at a little over 50% and no significant association with age is found. The 
same applies when life shortening is explicitly intended (NTD+). For euthanasia and assisted 
suicide (EAS) we see a bivariately significant decrease in rate with increasing age, but this 
does not hold in multivariate analysis on the count of cause and place of death (not in table). 
Lastly, the incidence of life ending without explicit patient request (LAWER) is not 
associated with age and amounts to 1.2% and 3.8% of non-sudden deaths. 
Table 2 ELD incidence 2007 by age groups, non-sudden deaths (weighted %) 
 Patient age (yrs) p-value* 
−45 45-64 65-69 70-74 75-79 80-84 85-89 90+ biv. multiv. 
n = 76 n = 474 n = 217 n = 293 n = 462 n = 483 n = 391 n = 333   
APS 74,4 61,5 59,0 62,8 50,4 50,5 46,7 46,5 <0.001 0.119 
APS+ 18,6 13,4 13,1 15,5 12,4 12,5 9,6 6,8 0.017 0.504 
NTD 54,4 53,8 53,2 56,6 50,1 52,4 50,1 51,7 0.800 0.761 
NTD+ 21,1 18,7 19,8 17,9 21,0 15,9 15,9 13,0 0.107 0.215 
EAS 6,2 6,8 4,8 4,5 3,0 2,5 0,5 0,1 <.001 0.359 
LAWER 2,8 1,2 3,8 3,0 3,0 3,1 3,4 1,5 0.435 0.671 
Unweighted number of cases, weighted percentages 
*p-values calculated by logistic regression (age entered as categorical variable). Multivariate 
regression with confounders sex, marital status, cause of death, place of death (no interaction 
effects); educational attainment not featured in multivariate model due to the large number of 
missings 
ELD: end-of-life decision; APS: intensified alleviation of pain and other symptoms; APS+: 
intensified alleviation of pain and other symptoms co-intending life shortening; NTD: non-
treatment decisions; NTD+: non-treatment decisions explicitly intending life shortening; 
EAS: euthanasia and physician-assisted suicide; LAWER: life ending acts without explicit 
patient request 
Figure 1 presents the Table 2 percentages graphically, supplemented by 1998 data, and Table 
3 shows the multivariate odds ratios for the various ELDs by age groups between 1998 and 
2007. Intensified alleviation of pain and symptoms (APS) is consistently more likely to be 
performed in 2007 than in 1998, in all age groups. With life shortening co-intended (APS+) 
the reverse picture emerges: this decision is in every age group less likely in 2007 than in 
1998. Non-treatment decisions (NTD) are more likely in 2007 for the age groups 65–79 years 
and 80+ years than in 1998. Decisions not to treat with an explicit life shortening intention 
(NTD+) are less likely in 2007 than in 1998 for the oldest age group (80+ years). In the age 
group 65–79 years euthanasia and assisted suicide (EAS) are 2.4 times more likely to occur in 
2007 than in 1998; for other age groups the odds ratio is not statistically significant. As 
concerns life ending acts without explicit request (LAWER), patients younger than 65 years 
were 5.9 times less likely to undergo this decision in 2007 than in 1998 and patients aged 65–
79 1.9 times less likely. Patients aged 80 or over did not have a significantly different chance 
of life ending without request than in 1998. 
Figure 1 ELD rates 1998–2007 by age groups, non-sudden deaths (weighted %) 
ELD rates 1998–2007 by age groups, non-sudden deaths (weighted %) 
Table 3 Multivariate ORs (95% CI) 2007 vs. 1998 for ELD incidences by age groups 
(weighted)* 
 Patient age (yrs)  
−65 65-79 80+ all ages 
APS 1,46 (1,01-2,11) 1,57 (1,23-2,01) 1,83 (1,49-2,25) 1,66 (1,44-1,91) 
APS+ 0,45 (0,29-0,69) 0,71 (0,51-0,97) 0,70 (0,52-0,95) 0,64 (0,53-0,78) 
NTD 1,25 (0,88-1,76) 1,40 (1,11-1,77) 1,23 (1,01-1,50) 1,30 (1,13-1,49) 
NTD+ 0,74 (0,49-1,14) 0,91 (0,68-1,21) 0,60 (0,47-0,77) 0,73 (0,62-0,87) 
EAS 1,63 (0,72-3,72) 2,42 (1,04-5,65) 0,86 (0,36-2,06) 1,60 (0,99-2,58) 
LAWER 0,17 (0,06-0,47) 0,52 (0,30-0,93) 0,87 (0,49-1,54) 0,56 (0,39-0,79) 
*1998 is the reference year. Odds ratios (ORs) and 95% confidence intervals (CI) in bold 
indicate statistically significant differences between 1998 and 2007 (multivariate logistic 
regression with confounders sex, marital status, cause of death, place of death - no interaction 
effects; educational attainment not featured in multivariate model due to the large number of 
missings) 
ELD: end-of-life decision; APS: intensified alleviation of pain and other symptoms; APS+: 
intensified alleviation of pain and other symptoms co-intending life shortening; NTD: non-
treatment decisions; NTD+: non-treatment decisions explicitly intending life shortening; 
EAS: euthanasia and physician-assisted suicide; LAWER: life ending acts without explicit 
patient request 
Decision making process of ELDs 
Concerning the process of decision making where intensified alleviation of pain and other 
symptoms (APS) was the most important decision, younger patients are more often included 
in the discussion and more often formulate an explicit request than do older patients (Table 
4). This association between age, inclusion in discussion and request rate remains significant 
after multivariate controlling for confounders. The same multivariate association is found in 
discussion with the patient about intensifying pain and symptom treatment with life 
shortening co-intention (APS+): 70% of patients younger than 65 years are included 
compared with 19% of patients older than 80 years. Also, for intensified pain and symptom 
treatment older patients were more often deemed lacking in capacity. For all other end-of-life 
decisions the proportion of patients lacking in capacity did not differ significantly across age 
groups, though a higher rate of incompetence is found in older patient groups. Palliative care 
(PC) specialists were more often consulted in relation to younger patients than to the oldest 
patients for intensified pain and symptom alleviation. 
Table 4 Decision making with patient, family and caregivers 2007 by ELD and age groups (weighted %) 
Most important ELD APS APS+ NTD NTD+ EAS LAWER 
Patient age (yrs) −65 65-79 80+ −65 65-79 80+ −65 65-79 80+ −65 65-79 80+ −65 65-79 80+ −65 65-79 80+ 
N (unweighted) 288 461 500 40 71 55 93 190 285 63 121 138 51 64 27 10 28 28 
discussed with patient 41 26 17 70 47 19 25 24 17 27 24 24 100 100 100 33 24 19 
discussed and explicit request by patient 29 19 11 57 30 15 11 10 10 14 10 15 100 100 100 0 0 0 
not discussed with patient 59 74 84 30 53 81 75 76 83 73 76 76 0 0 0 67 76 81 
not discussed and patient not competent 42 58 75 20 45 70 66 73 79 66 75 74 - - - 60 65 74 
not discussed but wish stated by patient 8 12 15 5 20 11 9 15 21 9 20 20 - - - 17 23 47 
discussed with family 54 60 53 65 72 73 33 36 40 79 73 74 78 81 64 67 76 83 
discussed with colleague(s) 43 37 31 57 54 38 63 57 41 76 63 49 85 83 53 67 64 53 
discussed with PC specialist 24 27 17 46 44 16 8 15 18 11 20 23 54 60 21 50 12 12 
discussed with nurse(s) 28 43 37 44 58 46 42 40 46 44 46 53 58 61 29 50 56 27 
Percentages in bold indicate statistically significant differences between age groups after bivariate logistic regression, p < .05 
Underlined percentages indicate statistically significant differences between age groups after multivariate logistic regression controlling for 
confounders (sex, marital status, cause of death, place of death - no interaction effects; educational attainment not featured in multivariate model 
due to the large number of missings), p < .05 
ELD: end-of-life decision; APS: intensified alleviation of pain and other symptoms; APS+: intensified alleviation of pain and other symptoms 
co-intending life shortening; NTD: non-treatment decisions; NTD+: non-treatment decisions explicitly intending life shortening; EAS: 
euthanasia and physician-assisted suicide; LAWER: life ending acts without explicit patient request 
No significant age associations were found for inclusion of the patient in the discussion or for 
discussion with family or other caregivers in non-treatment decisions. The rate of discussion 
with colleague physicians was bivariately negatively associated with increasing age, whereas 
palliative care (PC) consultation was multivariately positively associated with increasing 
patient age: for non-treatment decisions in patients older than 80 years, the rate of PC 
consultation was 18% whereas the rate in younger patients was 8%. The rate for NTD + rises 
from 11% in patients younger than 65 years to 23% in those older than 80 years. NTD + is the 
only type of ELD where patients aged 80 or over were significantly more often included in 
decision making than in 1998 (not in table). 
Euthanasia and assisted suicide are by definition always discussed with the patient. No 
multivariate effect of age on decision making was found for these acts. Bivariately, a 
colleague physician is more often consulted in younger patients receiving euthanasia or 
assisted suicide (85% and 83%) than in the oldest patients (53%). There were also no 
multivariately controlled effects of age on decision making in life ending without request but 
the rate of PC consultation was bivariately significantly higher among patient under 65 years 
(50%) than among patients over 65 years (12%). 
Granting or rejecting euthanasia requests 
In 1998 younger patients tended to formulate a request for euthanasia more often than older 
patients but this finding was not significant after multivariate testing (Table 5). Also, the 
proportion of requests for euthanasia that were granted did not differ significantly between 
age groups. In 2007 the rate of euthanasia requests did differ significantly between age 
groups: the rate was 10.3% for patients younger than 65 years, 5.6% for patients aged 65 to 
79 and 2.6% for patients aged 80 or older. Patients younger than 80 years were significantly 
more likely to see their request granted than those in the oldest patient group but this 
association did not hold after multivariate testing (principal confounder: cause of death). 
When examining the reasons for granting a euthanasia request, physicians indicated that ‘life 
should not be prolonged needlessly’ more often when it concerned older patients (p = 0.016). 
This finding proved insignificant in multivariate analysis with other confounders (p = 0.066). 
Physicians indicated having their own objections in principle as a relevant reason for 
rejecting a euthanasia request more often with the oldest patients (in 22%), but this 
significant association also disappeared after multivariate testing. 
Table 5 Granted and rejected euthanasia/assisted suicide (EAS) requests 1998 and 2007 
by age groups (weighted %) 
 Patient age (yrs) p-value* 
−65 65-79 80+ biv. multiv. 
1998 n = 181 n = 408 n = 640   
Request for EAS 7,6 4,6 3,9 0.097 0.326 
granted 53 32 35 0.392 0.909 
rejected 47 68 65   
2007 n = 550 n = 972 n = 1207   
Request for EAS 10,3 5,6 2,6 <0.001 0.034 
granted 63 64 38 0.039 0.296 
rejected 37 36 62   
Reasons for granting (n = 51) (n = 64) (n = 27)   
no prospect of improvement 92 77 87 0.367 0.715 
request/wish of the patient 89 94 100 0.736 0.465 
severe symptoms (excl. pain) 81 67 71 0.612 0.803 
severe pain 69 57 50 0.508 0.702 
loss of dignity 50 57 43 0.751 0.675 
low expected life quality 46 61 64 0.379 0.478 
expected further suffering 42 57 71 0.239 0.170 
life should not be prolonged needlessly 19 45 67 0.016 0.066 
request/wish of the family 19 20 50 0.095 0.651 
situation unbearable for family 19 16 20 0.916 0.914 
Reasons for rejecting (n = 33) (n = 27) (n = 25)   
death before request granted 60 47 32 0.230 0.548 
patient revoked request 20 12 17 0.808 0.994 
no well-considered request 7 11 13 0.823 0.494 
fear for legal consequences 7 18 0 0.104 >0.999 
suffering was not unbearable 7 0 17 0.155 0.485 
principle objections 0 0 22 0.022 0.389 
medical condition not hopeless 0 0 13 0.110 0.818 
institutional policy 0 0 13 0.110 >0.999 
patient was not terminally ill 0 0 4 0.492 >0.999 
no voluntary request 0 0 0 >0.999 >0.999 
other reason(s) 7 12 9 0.879 0.832 
Unweighted number of cases, weighted percentages 
*p-values calculated by logistic regression. Multivariate regression with confounders sex, 
marital status, cause of death, place of death (no interaction effects); educational attainment 
not featured in multivariate model due to the large number of missings 
Discussion 
This study found a number of differences between age groups in end-of-life decision making. 
In 2007 the incidence of intensified pain and symptom treatment and also of euthanasia and 
assisted suicide decreased significantly with increasing age, but not after multivariate testing 
with a number of confounders. Comparing 2007 with 1998, decisions to intensify alleviation 
of pain and symptoms, not to treat, and to perform euthanasia or assisted suicide were more 
likely to have been made for intensified pain and symptom alleviation in all age groups, for 
non-treatment decisions in patients aged 65 or over and for euthanasia and assisted suicide 
only in the 65–79 age group. Alleviation of pain and symptoms with a co-intention to hasten 
death occurred less often in 2007 than in 1998 in all age groups whereas non-treatment 
decisions with explicitly intended life shortening were less likely only for the oldest age 
group and life ending without explicit request less likely only for patients younger than 80 
years. As concerns decision making with the patient in 2007 this was more often done with 
younger patients for intensified alleviation of pain and symptoms. For such decisions a 
palliative care specialist was less often involved when the patient was 80 years or older while 
the opposite was found for non-treatment decisions. Lastly, in 2007 the rate of euthanasia 
requests decreased with increasing age and the oldest patients saw their request rejected more 
often, though this latter finding was not significant after multivariate testing. 
Though the occurrence of the various ELDs in 2007 was not directly influenced by patient 
age, we did find a bivariate (negative) association of age with intensified pain and symptom 
alleviation and with euthanasia/assisted suicide. It is well known that older patients have 
different socio-demographic and clinical profiles from younger ones, as Table 1 shows. The 
main diagnosis and place of death seemed to be the factors determining the likelihood of an 
end-of-life decision. This does not however mean that there is no problem related to age. The 
reality remains that older patients are less likely to receive intensified pain and symptom 
treatment in the context of palliative care, something which is confirmed by the higher levels 
of consultation of palliative care experts for younger patient groups and which is consistent 
with earlier studies [8,29]. This is probably because elderly patients die from cancer 
relatively infrequently and palliative care is historically provided mainly to cancer patients 
[30-32]as the cancer trajectory is more predictable [2,30,33]. Generally, policy should aim at 
taking away barriers to equality between ages independently of diagnosis. Patients of all ages 
should be entitled to the same intensity and quality of care. If provision of palliative care is 
expanded to patients with non-malignant diagnoses, something which is widely advocated 
[30,32,33], the differences between age groups, and specifically the ‘undertreatment’ of the 
oldest, should disappear. This is of course assuming that the lower incidence of pain and 
symptom alleviation in older patients is a sign of undertreatment; hypotheses explaining the 
age disparity in palliative care consumption include the suggestion that pain and other 
symptoms are less often recognised in elderly patients [8,21,34], that elderly patients are less 
able to report them [16,33] or that they have learned to cope with long-term pain [35,36]. 
These hypotheses seem to be disproved by our data; the issue should be investigated more 
deeply. 
As concerns euthanasia and assisted suicide, it is not possible to make qualitative/moral 
judgments on the effect of age on occurrence, which in our multivariate model was explained 
by differences between cancer and non-cancer diagnosis. What we know is that there is more 
acceptance of euthanasia among younger generations [37]. Our finding that older patient 
groups request euthanasia less often than do younger groups corroborates this. This can be 
related to generational effects and also to differences in educational attainment [38]. 
Unfortunately, the latter factor could not be included in the analysis. It is significant, 
however, that there is no age-based difference in the proportion of requests granted. Our 
study did find a bivariate relationship ie fewer requests granted in the 80+ age group than in 
younger groups, but this disappeared after multivariate testing again due to differences 
between cancer and non-cancer diagnosis. So it seems that non-cancer patients are less likely 
to have their request for euthanasia granted. This is not problematic per se as the Belgian 
euthanasia law prescribes rigorous criteria for eligibility [26], and these criteria are thought to 
be less easily confirmed in non-cancer patients. Indeed, because legal criteria such as 
‘unbearable suffering’ are so difficult to define in practice, cancer patients may be viewed as 
the ‘ideal’ euthanasia patient against which euthanasia requests from non-cancer patients are 
compared and often deemed insufficiently in accordance with the euthanasia law [39]. 
However, euthanasia among cancer patients may be socially more acceptable making 
physicians more reluctant to grant euthanasia to non-cancer patients. If this is the case then 
the difference between the options available to cancer and non-cancer patients becomes 
problematic. More research is needed to elucidate this. 
One finding that is not in line with previous research [8,12,13] is that the incidence of non-
treatment decisions does not increase with age; if anything, our analyses show a tendency 
towards fewer decisions to forgo life-sustaining or life-saving treatment as age increases, 
particularly where the hastening of death is explicitly intended. Many studies suggest that 
considerations of age may come into play when deciding whether to initiate or continue 
treatment at the end of life, in surveys of both attitudes and actual practice [8,11-14]. In 
Flanders, Belgium, this phenomenon seems nonexistent or marginal at most. In past studies in 
Belgium (and elsewhere) using the same method we did find age differences in incidence of 
non-treatment decisions, but this is because we included only the most important ELD for 
each case [3,27]. When analysing cases permitting more than one ELD per case, we find no 
age differences in NTD incidence. Further research could study whether different types of 
non-treatment decisions (medication, hydration/nutrition, CPR, respiration, oncotherapy, 
surgery, dialysis) have divergent frequencies in various age groups. 
Though age may not be a determining factor in the incidence of end-of-life decisions, it is all 
the more important in decision making. The older the patient, the less often he or she is 
involved in decision making to intensify pain and symptom alleviation, and the less likely he 
or she is to explicitly request it. This confirms the findings of other studies which offer 
relevant explanatory hypotheses of lower assertiveness or empowerment and less aspiration 
to autonomy in older patients [11,18]. Elderly patients often put all faith in the physician, 
who is viewed as the expert as well as the moral authority in what is perceived as a 
hierarchical relationship [18,40]. Elderly patients were in our study also more frequently 
found to be lacking in capacity to be involved in end-of-life decision making. As consensus 
continues to grow that respecting the patient’s wishes is paramount in these decisions 
[14,15,19,32], the need for advance care planning, or at least an exploration of preferences 
before the patient loses capacity is thus very clear, particularly in the oldest patient groups 
[2,19,41]. Save for non-treatment decisions, the inclusion rate of older patients in end-of-life 
decisions has not significantly increased since 1998. Additionally, we found no 
accompanying higher rate of family inclusion or consultation of colleagues or nurses in 
decision making in older patients than there had been a decade earlier. It is thus warranted to 
conclude that older patients are at higher risk of paternalism. Advance care planning 
initiatives need to target the oldest patient population specifically. 
What emerges clearly from our findings is that there is no evidence to support the slippery 
slope hypothesis [24,25] in elderly patients, let alone in general. Life ending acts without 
explicit patient request have not risen in incidence since the enactment of the euthanasia law; 
to the contrary, LAWER incidence has decreased significantly since 1998 in the age groups 
below 80 years though in the oldest patients the rate has remained the same. Also elderly 
patients are not more at risk of LAWER than younger patients in 2007. Our findings thus do 
not confirm the ‘slippery slope’ hypothesis either in general or in elderly patients. It is, 
however, noteworthy that the LAWER rate has remained stagnant since 1998 in the oldest 
age group while it is declining in younger age groups. This may be an indication of persistent 
paternalism in decision making for elderly patients, and further argument for focusing 
advance care initiatives on the oldest. The development of the incidence of a controversial 
decision like LAWER in older patients needs to be closely monitored, as adverse effects 
could only become apparent after a longer period of legalised euthanasia. 
There are a number of limitations inherent in this study. Given the length of time between the 
death in question and completing the questionnaire, we cannot exclude the influence of 
memory bias in the reporting physicians. Also, our survey includes only the perspective of 
the treating physicians and not those of relatives or other caregivers. The more than 40% non-
response rate may have generated bias in the results, although the data were weighted to 
correct for this. As our study depends on a conceptualisation of reality, the classification 
scheme of ELDs as approximation may not fully reflect actual practices and ignore the 
complexity of end-of-life decision making. Furthermore, although we have information on 
the process of decision making, we do not know what the discussion outcomes were. Finally, 
we could not include in the analyses the patient’s educational attainment as confounder to age 
due to the high proportion of missing cases, although this may be an important determining 
factor in end-of-life decision making. 
Conclusion 
We conclude that age is not a determining factor in the rate of end-of-life decisions, but plays 
a role in the preceding decision making process. Whereas the rates of non-treatment decisions 
and life ending without request do not differ between age groups, those of intensified pain 
and symptom alleviation and euthanasia/assisted suicide requests do but are determined 
predominantly by diagnosis ie cancer/non-cancer. Conversely, patient involvement in 
decision making ís determined by patient age independently of other factors and this suggests 
the need for a focus on advance care planning initiatives for elderly patients. Comparison 
with data from before Belgian euthanasia regulation yielded no evidence of a ‘slippery slope’ 
as fewer LAWER cases were reported since the euthanasia law. Nonetheless this needs to be 
monitored closely in the future. 
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